Cephalexin Safety in G6PD-Deficient Patients
Evidence-Based Safety Profile
- The American Academy of Pediatrics and other guideline societies recommend that only seven medications are definitively contraindicated in G6PD deficiency, and cephalexin is not among them 1
Clinical Use in Pediatric Patients
- The Infectious Diseases Society of America recommends cephalexin for treating methicillin-susceptible Staphylococcus aureus infections in children, with a preferred oral dose of 75-100 mg/kg/day divided into 3 or 4 doses, with no special restrictions or warnings for G6PD-deficient patients 2, 3, 4
Important Caveats
- The severity of G6PD deficiency varies by genetic variant, with the Mediterranean variant being more severe and the African variant being milder 1, 5
- When using cephalexin in a G6PD-deficient patient, monitor for signs of hemolysis, including jaundice, dark urine, fatigue, and pallor 1